← All organizations

Proteon Therapeutics

Proteon Therapeutics

For profitWebsite ↗

Also known as: Proteon Therapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 1, 2016

Defunct as of Jan 1, 2020

Timeline

2000s

Jun 1, 2001
Proteon Therapeutics— Founded

2020s

Jan 1, 2020
Proteon Therapeutics— Defunct

Drugs by trial phase (1 distinct, 8 trials)

Phase 3 (1 own, 0 via acquisition)

vonapanitase

Indications

Studied for

Recent trials (9)

NCT02956993Lead sponsorPhase 1Nov 1, 2016
NCT02953496Lead sponsorPhase 1Oct 26, 2016
NCT02414841Lead sponsorPhase 3Aug 1, 2015
NCT02110901Lead sponsorPhase 3Jul 1, 2014
NCT01616290Lead sponsorPhase 1Oct 1, 2012
NCT01305824Lead sponsorPhase 2Mar 1, 2011
NCT01001351Lead sponsorPhase 1/Phase 2Sep 1, 2009
NCT01001351Study directorPhase 1/Phase 2Sep 1, 2009
NCT00679991Lead sponsorPhase 1/Phase 2Nov 1, 2008

Details

Founded: Waltham, MA, US Jun 1, 2001
Last known activity: Nov 1, 2016